NCT03803748 - A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

May 2, 2022

Study Completion Date

August 31, 2022

Conditions

Dry Eye Syndromes

Interventions

DEVICE

Eyestil Plus®

• To demonstrate the non-inferiority of Eyestil Plus® compared to Vismed Multi® in terms of clinical performance as detected by a reduction of keratitis lesions objectified by staining tests after 1 month of treatment, in patients with moderate to severe dry eye syndrome with keratoconjunctivitis

Trial Locations (12)

Unknown

CHU de Bordeaux - Hôpital Pellegrin, Bordeaux

Chu Morvan, Brest

CHU François Mitterand, Dijon

Hôpital de la Croix Rousse, Lyon

Centre Monticelli, Marseille

Hopital La Timone Adultes, Marseille

CHU de Nice - Hôpital Pasteur, Nice

CHU Saint Etienne/Hôpital Nord, Saint-Etienne

Hopital Bretonneau, Tours

Instituto Oftalmologico Fernandez-Vega, Madrid

Hospital Universitario Virgen Macarena, Seville

Hospital Recoletas Campo Grande, Valladolid

All Listed Sponsors

lead

SIFI SpA

INDUSTRY